Skip to main content

Briggs Morrison

Board Member

Carisma Therapeutics Inc.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Briggs Morrison

Briggs Morrison is recorded as Board Member at Carisma Therapeutics Inc.. Carisma Therapeutics Inc. reported in an 8-K filed October 15, 2025 that Briggs Morrison resigned as director, effective October 15, 2025. Carisma Therapeutics Inc. reported in an 8-K filed March 8, 2023 that Briggs Morrison was appointed Board, effective March 7, 2023.

“On October 14, 2025, each of John Hohneker, M.D., Briggs Morrison, M.D. and David Scadden M.D. notified the Company of such director's decision to resign from the Company's board of directors (the "Board") and all committees thereof, effective October 15, 2025.”
Carisma Therapeutics Inc. Form 8-K, filed October 15, 2025 · Read the filing
“the Board and its committees were reconstituted, consisting of six directors designated by Carisma, who are Steven Kelly, Regina Hodits, Ph.D., Briggs Morrison, M.D., Björn Odlander, M.D., Ph.D., Chidozie Ugwumba and Sanford Zweifach, and one director designated by the Company, who is Michael Torok.”
Carisma Therapeutics Inc. Form 8-K, filed March 8, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Carisma Therapeutics Inc.

    Board Member

    SEC 8-K

    Current

    2023-03-07–present

  • Carisma Therapeutics Inc.

    Board Member

    SEC 8-K

    2023-03-07–2025-10-15

Company network

Recorded roles and call appearances connecting this person to public companies.

Carisma Therapeutics Inc.

Current role

Board Member

2023-03-07–present

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.